Skip to main content
Fig. 1 | BMC Infectious Diseases

Fig. 1

From: Critically ill patients with diabetes and Middle East respiratory syndrome: a multi-center observational study

Fig. 1

Panel a: Time-to-clearance of the Middle East respiratory syndrome coronavirus (MERS-CoV) RNA among patients with diabetes and no diabetes. Time to clearance was defined as the time taken from the date of ICU admission to having two negative RT-PCR tests not followed by positive test. Log-rank test is used to calculate the P-value. Panel b: Kaplan Meir curves for survival among patients with diabetes and no diabetes and Middle East respiratory syndrome (MERS)

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us